A hidden “jack-in-the-box” mechanism inside T cells may hold the key to unlocking more powerful cancer immunotherapies.
Scientists have discovered that T cell receptors activate through a hidden spring-like motion that had never been seen before ...
Flagship Pioneering, a scientific innovation engine for transformative platforms and products, today announced a research program under its strategic collaboration with Pfizer whereby Flagship-founded ...
One of the most exciting advances in cancer treatments in the past decade is the development of T cell immunotherapies, in ...
Ryan Notti (left) and Thomas Walz (right) discovered new characteristics of a T cell receptor that are essential to a variety ...
Automated TCR-T production streamlines personalized immunotherapy, reducing patient burden and improving engineered T cell quality.
Researchers have developed a new strategy that allows engineered T cells to recognize and respond to a single tumour antigen ...
The company plans to announce Phase 1b interim data by mid-2026, and the TENACITY-01 study is expected to be completed by late 2028. This timing enables progression to Phase 2 evaluation following ...
Flagship Pioneering, a scientific innovation engine for transformative platforms and products, today announced a research program under its strategic collaboration with Pfizer whereby Flagship-founded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results